AI Article Synopsis

  • Intermittent hypoxia (IH), which means going without oxygen for short times, can cause fatty liver disease when there's not enough copper in the diet.
  • In experiments with mice, those with low copper levels showed more liver problems and stress when exposed to IH compared to those with normal copper levels.
  • The researchers found that low copper increased certain proteins that help fat build up in the liver and lead to more damage, suggesting that not eating enough copper can make liver issues worse when facing IH.

Article Abstract

Intermittent hypoxia (IH) is an independent risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD). Copper deficiency can disrupt redox homeostasis, iron, and lipid metabolism. Here, we investigated whether hepatic copper deficiency plays a role in IH-associated MAFLD and explored the underlying mechanism(s). Male C57BL/6 mice were fed a western-type diet with adequate copper (CuA) or marginally deficient copper (CuD) and were exposed separately to room air (RA) or IH. Hepatic histology, plasma biomarkers, copper-iron status, and oxidative stress were assessed. An in vitro HepG2 cell lipotoxicity model and proteomic analysis were used to elucidate the specific targets involved. We observed that there were no differences in hepatic phenotypes between CuA-fed and CuD-fed mice under RA. However, in IH exposure, CuD-fed mice showed more pronounced hepatic steatosis, liver injury, and oxidative stress than CuA-fed mice. IH induced copper accumulation in the brain and heart and exacerbated hepatic copper deficiency and secondary iron deposition. In vitro, CuD-treated cells with IH exposure showed elevated levels of lipid accumulation, oxidative stress, and ferroptosis susceptibility. Proteomic analysis identified 360 upregulated and 359 downregulated differentially expressed proteins between CuA and CuD groups under IH; these proteins were mainly enriched in citrate cycle, oxidative phosphorylation, fatty acid metabolism, the peroxisome proliferator-activated receptor (PPAR)α pathway, and ferroptosis. In IH exposure, CuD significantly upregulated the ferroptosis-promoting factor arachidonyl-CoA synthetase long chain family member (ACSL)4. ACSL4 knockdown markedly eliminated CuD-induced ferroptosis and lipid accumulation in IH exposure. In conculsion, IH can lead to reduced hepatic copper reserves and secondary iron deposition, thereby inducing ferroptosis and subsequent MAFLD progression. Insufficient dietary copper may worsen IH-associated MAFLD.

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.202400840RDOI Listing

Publication Analysis

Top Keywords

hepatic copper
16
copper deficiency
12
oxidative stress
12
copper
9
intermittent hypoxia
8
metabolic dysfunction-associated
8
dysfunction-associated fatty
8
fatty liver
8
liver disease
8
ih-associated mafld
8

Similar Publications

Pregnancy with Wilson's Disease: A Case Series.

Mymensingh Med J

January 2025

Dr Mousumi Saha, Assistant Professor, Fetomaternal Medicine Subspeciality (FCPS) Course Student, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh; E-mail:

Wilson's disease is an autosomal recessive disorder that affects copper transport due to deficiency of ceruloplasmin and causes deposition of copper mainly in the liver, brain and cornea. It causes hepatic and/or neuropsychiatric manifestations. This copper deposition causes cirrhosis of the liver, encephalopathy and liver failure.

View Article and Find Full Text PDF

Iron and Copper Liver Concentrations in Wilson Disease.

J Gastrointestin Liver Dis

December 2024

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Background And Aims: Wilson disease (WD) results in the defective incorporation of copper into ceruloplasmin as well as decreased biliary copper excretion. Secondary iron overload has also been associated with WD; however, the prevalence is currently unknown. This study aims to determine the prevalence of potential secondary iron overload in patients suspected to have WD.

View Article and Find Full Text PDF
Article Synopsis
  • * After exposing rats to CuO for three weeks, researchers administered DHEA and quercetin for another three weeks, monitoring liver enzyme levels, antioxidant statuses, and signs of cell damage and death.
  • * Results showed that CuO exposure led to significant liver toxicity, but treatment with DHEA and quercetin reduced this damage, with their combined effect being particularly effective in improving liver health.
View Article and Find Full Text PDF

Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism. The genetic defect in WD affects the gene, which encodes the ATP7B transmembrane protein, which is essential for maintaining normal copper homeostasis in the body. It is primarily expressed in the liver and acts by incorporating copper into ceruloplasmin (Cp), the major copper transport protein in the blood.

View Article and Find Full Text PDF
Article Synopsis
  • Wilson disease (WD) is a rare genetic disorder affecting copper metabolism, leading to copper buildup in the liver and brain, analyzed using data from the French national health database between 2010 and 2019.
  • The study identified 2287 patients with a prevalence rate of 1 in 33,898 individuals; most patients were around 40 years old and exhibited significant morbidity with 44.2% having liver issues, 33.0% neurological symptoms, and 18.1% psychiatric problems.
  • The research highlights the substantial healthcare costs associated with WD, averaging 4273.7€ per patient annually for hospitalization and significant sick leave expenses, indicating a considerable economic burden on affected individuals and the healthcare system.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!